The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peptide CXO Market Research Report 2025
Synopsis
The global market for Peptide CXO was valued at US$ 3211 million in the year 2024 and is projected to reach a revised size of US$ 6459 million by 2031, growing at a CAGR of 10.6% during the forecast period.
Peptide CXO refers to the outsourcing of research, development, manufacturing, and commercialization processes of peptide-based drugs to specialized Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), and Contract Manufacturing Organizations (CMOs). These services include peptide synthesis optimization, process development, quality control, clinical research, regulatory submissions, and large-scale production. The Peptide CXO model helps pharmaceutical companies reduce R&D and manufacturing costs, accelerate time-to-market, and ensure the quality and stability of peptide drug supply chains.
North American market for Peptide CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peptide CXO in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peptide CXO include Polypeptide, Bachem, LONZA, Bicycle, Pepscan, JPT Peptide, WuXi AppTec, Asymchem, Jiangsu Sinopep-Allsino Biopharmaceutical, Chinese Peptide Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CXO.
The Peptide CXO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide CXO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Polypeptide
Bachem
LONZA
Bicycle
Pepscan
JPT Peptide
WuXi AppTec
Asymchem
Jiangsu Sinopep-Allsino Biopharmaceutical
Chinese Peptide Company
AmbioPharm
ReaLi Tide Biological Technology
GL Biochem
Shenzhen JYMed Technology
Chengdu Shengnuo Biotechnology
Segment by Type
CRO
CMO/CDMO
Segment by Application
Pharmaceutical Companies
Biotech Companies and Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide CXO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Peptide CXO was valued at US$ 3211 million in the year 2024 and is projected to reach a revised size of US$ 6459 million by 2031, growing at a CAGR of 10.6% during the forecast period.
Peptide CXO refers to the outsourcing of research, development, manufacturing, and commercialization processes of peptide-based drugs to specialized Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs), and Contract Manufacturing Organizations (CMOs). These services include peptide synthesis optimization, process development, quality control, clinical research, regulatory submissions, and large-scale production. The Peptide CXO model helps pharmaceutical companies reduce R&D and manufacturing costs, accelerate time-to-market, and ensure the quality and stability of peptide drug supply chains.
North American market for Peptide CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide CXO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peptide CXO in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peptide CXO include Polypeptide, Bachem, LONZA, Bicycle, Pepscan, JPT Peptide, WuXi AppTec, Asymchem, Jiangsu Sinopep-Allsino Biopharmaceutical, Chinese Peptide Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide CXO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide CXO.
The Peptide CXO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide CXO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide CXO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Polypeptide
Bachem
LONZA
Bicycle
Pepscan
JPT Peptide
WuXi AppTec
Asymchem
Jiangsu Sinopep-Allsino Biopharmaceutical
Chinese Peptide Company
AmbioPharm
ReaLi Tide Biological Technology
GL Biochem
Shenzhen JYMed Technology
Chengdu Shengnuo Biotechnology
Segment by Type
CRO
CMO/CDMO
Segment by Application
Pharmaceutical Companies
Biotech Companies and Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide CXO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide CXO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRO
1.2.3 CMO/CDMO
1.3 Market by Application
1.3.1 Global Peptide CXO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies and Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide CXO Market Perspective (2020-2031)
2.2 Global Peptide CXO Growth Trends by Region
2.2.1 Global Peptide CXO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide CXO Historic Market Size by Region (2020-2025)
2.2.3 Peptide CXO Forecasted Market Size by Region (2026-2031)
2.3 Peptide CXO Market Dynamics
2.3.1 Peptide CXO Industry Trends
2.3.2 Peptide CXO Market Drivers
2.3.3 Peptide CXO Market Challenges
2.3.4 Peptide CXO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide CXO Players by Revenue
3.1.1 Global Top Peptide CXO Players by Revenue (2020-2025)
3.1.2 Global Peptide CXO Revenue Market Share by Players (2020-2025)
3.2 Global Top Peptide CXO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide CXO Revenue
3.4 Global Peptide CXO Market Concentration Ratio
3.4.1 Global Peptide CXO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide CXO Revenue in 2024
3.5 Global Key Players of Peptide CXO Head office and Area Served
3.6 Global Key Players of Peptide CXO, Product and Application
3.7 Global Key Players of Peptide CXO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide CXO Breakdown Data by Type
4.1 Global Peptide CXO Historic Market Size by Type (2020-2025)
4.2 Global Peptide CXO Forecasted Market Size by Type (2026-2031)
5 Peptide CXO Breakdown Data by Application
5.1 Global Peptide CXO Historic Market Size by Application (2020-2025)
5.2 Global Peptide CXO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide CXO Market Size (2020-2031)
6.2 North America Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide CXO Market Size by Country (2020-2025)
6.4 North America Peptide CXO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide CXO Market Size (2020-2031)
7.2 Europe Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide CXO Market Size by Country (2020-2025)
7.4 Europe Peptide CXO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide CXO Market Size (2020-2031)
8.2 Asia-Pacific Peptide CXO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide CXO Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide CXO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide CXO Market Size (2020-2031)
9.2 Latin America Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide CXO Market Size by Country (2020-2025)
9.4 Latin America Peptide CXO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide CXO Market Size (2020-2031)
10.2 Middle East & Africa Peptide CXO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide CXO Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide CXO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Polypeptide
11.1.1 Polypeptide Company Details
11.1.2 Polypeptide Business Overview
11.1.3 Polypeptide Peptide CXO Introduction
11.1.4 Polypeptide Revenue in Peptide CXO Business (2020-2025)
11.1.5 Polypeptide Recent Development
11.2 Bachem
11.2.1 Bachem Company Details
11.2.2 Bachem Business Overview
11.2.3 Bachem Peptide CXO Introduction
11.2.4 Bachem Revenue in Peptide CXO Business (2020-2025)
11.2.5 Bachem Recent Development
11.3 LONZA
11.3.1 LONZA Company Details
11.3.2 LONZA Business Overview
11.3.3 LONZA Peptide CXO Introduction
11.3.4 LONZA Revenue in Peptide CXO Business (2020-2025)
11.3.5 LONZA Recent Development
11.4 Bicycle
11.4.1 Bicycle Company Details
11.4.2 Bicycle Business Overview
11.4.3 Bicycle Peptide CXO Introduction
11.4.4 Bicycle Revenue in Peptide CXO Business (2020-2025)
11.4.5 Bicycle Recent Development
11.5 Pepscan
11.5.1 Pepscan Company Details
11.5.2 Pepscan Business Overview
11.5.3 Pepscan Peptide CXO Introduction
11.5.4 Pepscan Revenue in Peptide CXO Business (2020-2025)
11.5.5 Pepscan Recent Development
11.6 JPT Peptide
11.6.1 JPT Peptide Company Details
11.6.2 JPT Peptide Business Overview
11.6.3 JPT Peptide Peptide CXO Introduction
11.6.4 JPT Peptide Revenue in Peptide CXO Business (2020-2025)
11.6.5 JPT Peptide Recent Development
11.7 WuXi AppTec
11.7.1 WuXi AppTec Company Details
11.7.2 WuXi AppTec Business Overview
11.7.3 WuXi AppTec Peptide CXO Introduction
11.7.4 WuXi AppTec Revenue in Peptide CXO Business (2020-2025)
11.7.5 WuXi AppTec Recent Development
11.8 Asymchem
11.8.1 Asymchem Company Details
11.8.2 Asymchem Business Overview
11.8.3 Asymchem Peptide CXO Introduction
11.8.4 Asymchem Revenue in Peptide CXO Business (2020-2025)
11.8.5 Asymchem Recent Development
11.9 Jiangsu Sinopep-Allsino Biopharmaceutical
11.9.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Details
11.9.2 Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview
11.9.3 Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Introduction
11.9.4 Jiangsu Sinopep-Allsino Biopharmaceutical Revenue in Peptide CXO Business (2020-2025)
11.9.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development
11.10 Chinese Peptide Company
11.10.1 Chinese Peptide Company Company Details
11.10.2 Chinese Peptide Company Business Overview
11.10.3 Chinese Peptide Company Peptide CXO Introduction
11.10.4 Chinese Peptide Company Revenue in Peptide CXO Business (2020-2025)
11.10.5 Chinese Peptide Company Recent Development
11.11 AmbioPharm
11.11.1 AmbioPharm Company Details
11.11.2 AmbioPharm Business Overview
11.11.3 AmbioPharm Peptide CXO Introduction
11.11.4 AmbioPharm Revenue in Peptide CXO Business (2020-2025)
11.11.5 AmbioPharm Recent Development
11.12 ReaLi Tide Biological Technology
11.12.1 ReaLi Tide Biological Technology Company Details
11.12.2 ReaLi Tide Biological Technology Business Overview
11.12.3 ReaLi Tide Biological Technology Peptide CXO Introduction
11.12.4 ReaLi Tide Biological Technology Revenue in Peptide CXO Business (2020-2025)
11.12.5 ReaLi Tide Biological Technology Recent Development
11.13 GL Biochem
11.13.1 GL Biochem Company Details
11.13.2 GL Biochem Business Overview
11.13.3 GL Biochem Peptide CXO Introduction
11.13.4 GL Biochem Revenue in Peptide CXO Business (2020-2025)
11.13.5 GL Biochem Recent Development
11.14 Shenzhen JYMed Technology
11.14.1 Shenzhen JYMed Technology Company Details
11.14.2 Shenzhen JYMed Technology Business Overview
11.14.3 Shenzhen JYMed Technology Peptide CXO Introduction
11.14.4 Shenzhen JYMed Technology Revenue in Peptide CXO Business (2020-2025)
11.14.5 Shenzhen JYMed Technology Recent Development
11.15 Chengdu Shengnuo Biotechnology
11.15.1 Chengdu Shengnuo Biotechnology Company Details
11.15.2 Chengdu Shengnuo Biotechnology Business Overview
11.15.3 Chengdu Shengnuo Biotechnology Peptide CXO Introduction
11.15.4 Chengdu Shengnuo Biotechnology Revenue in Peptide CXO Business (2020-2025)
11.15.5 Chengdu Shengnuo Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Peptide CXO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CRO
Table 3. Key Players of CMO/CDMO
Table 4. Global Peptide CXO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Peptide CXO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peptide CXO Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Peptide CXO Market Share by Region (2020-2025)
Table 8. Global Peptide CXO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Peptide CXO Market Share by Region (2026-2031)
Table 10. Peptide CXO Market Trends
Table 11. Peptide CXO Market Drivers
Table 12. Peptide CXO Market Challenges
Table 13. Peptide CXO Market Restraints
Table 14. Global Peptide CXO Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Peptide CXO Market Share by Players (2020-2025)
Table 16. Global Top Peptide CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CXO as of 2024)
Table 17. Ranking of Global Top Peptide CXO Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Peptide CXO Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Peptide CXO, Headquarters and Area Served
Table 20. Global Key Players of Peptide CXO, Product and Application
Table 21. Global Key Players of Peptide CXO, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peptide CXO Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Peptide CXO Revenue Market Share by Type (2020-2025)
Table 25. Global Peptide CXO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Peptide CXO Revenue Market Share by Type (2026-2031)
Table 27. Global Peptide CXO Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Peptide CXO Revenue Market Share by Application (2020-2025)
Table 29. Global Peptide CXO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Peptide CXO Revenue Market Share by Application (2026-2031)
Table 31. North America Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Peptide CXO Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Peptide CXO Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Peptide CXO Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Peptide CXO Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Peptide CXO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Peptide CXO Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Peptide CXO Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Peptide CXO Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Peptide CXO Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Peptide CXO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Peptide CXO Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Peptide CXO Market Size by Country (2026-2031) & (US$ Million)
Table 46. Polypeptide Company Details
Table 47. Polypeptide Business Overview
Table 48. Polypeptide Peptide CXO Product
Table 49. Polypeptide Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 50. Polypeptide Recent Development
Table 51. Bachem Company Details
Table 52. Bachem Business Overview
Table 53. Bachem Peptide CXO Product
Table 54. Bachem Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 55. Bachem Recent Development
Table 56. LONZA Company Details
Table 57. LONZA Business Overview
Table 58. LONZA Peptide CXO Product
Table 59. LONZA Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 60. LONZA Recent Development
Table 61. Bicycle Company Details
Table 62. Bicycle Business Overview
Table 63. Bicycle Peptide CXO Product
Table 64. Bicycle Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 65. Bicycle Recent Development
Table 66. Pepscan Company Details
Table 67. Pepscan Business Overview
Table 68. Pepscan Peptide CXO Product
Table 69. Pepscan Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 70. Pepscan Recent Development
Table 71. JPT Peptide Company Details
Table 72. JPT Peptide Business Overview
Table 73. JPT Peptide Peptide CXO Product
Table 74. JPT Peptide Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 75. JPT Peptide Recent Development
Table 76. WuXi AppTec Company Details
Table 77. WuXi AppTec Business Overview
Table 78. WuXi AppTec Peptide CXO Product
Table 79. WuXi AppTec Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 80. WuXi AppTec Recent Development
Table 81. Asymchem Company Details
Table 82. Asymchem Business Overview
Table 83. Asymchem Peptide CXO Product
Table 84. Asymchem Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 85. Asymchem Recent Development
Table 86. Jiangsu Sinopep-Allsino Biopharmaceutical Company Details
Table 87. Jiangsu Sinopep-Allsino Biopharmaceutical Business Overview
Table 88. Jiangsu Sinopep-Allsino Biopharmaceutical Peptide CXO Product
Table 89. Jiangsu Sinopep-Allsino Biopharmaceutical Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 90. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Development
Table 91. Chinese Peptide Company Company Details
Table 92. Chinese Peptide Company Business Overview
Table 93. Chinese Peptide Company Peptide CXO Product
Table 94. Chinese Peptide Company Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 95. Chinese Peptide Company Recent Development
Table 96. AmbioPharm Company Details
Table 97. AmbioPharm Business Overview
Table 98. AmbioPharm Peptide CXO Product
Table 99. AmbioPharm Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 100. AmbioPharm Recent Development
Table 101. ReaLi Tide Biological Technology Company Details
Table 102. ReaLi Tide Biological Technology Business Overview
Table 103. ReaLi Tide Biological Technology Peptide CXO Product
Table 104. ReaLi Tide Biological Technology Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 105. ReaLi Tide Biological Technology Recent Development
Table 106. GL Biochem Company Details
Table 107. GL Biochem Business Overview
Table 108. GL Biochem Peptide CXO Product
Table 109. GL Biochem Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 110. GL Biochem Recent Development
Table 111. Shenzhen JYMed Technology Company Details
Table 112. Shenzhen JYMed Technology Business Overview
Table 113. Shenzhen JYMed Technology Peptide CXO Product
Table 114. Shenzhen JYMed Technology Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 115. Shenzhen JYMed Technology Recent Development
Table 116. Chengdu Shengnuo Biotechnology Company Details
Table 117. Chengdu Shengnuo Biotechnology Business Overview
Table 118. Chengdu Shengnuo Biotechnology Peptide CXO Product
Table 119. Chengdu Shengnuo Biotechnology Revenue in Peptide CXO Business (2020-2025) & (US$ Million)
Table 120. Chengdu Shengnuo Biotechnology Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Peptide CXO Picture
Figure 2. Global Peptide CXO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peptide CXO Market Share by Type: 2024 VS 2031
Figure 4. CRO Features
Figure 5. CMO/CDMO Features
Figure 6. Global Peptide CXO Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Peptide CXO Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Biotech Companies and Research Institutions Case Studies
Figure 10. Peptide CXO Report Years Considered
Figure 11. Global Peptide CXO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Peptide CXO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Peptide CXO Market Share by Region: 2024 VS 2031
Figure 14. Global Peptide CXO Market Share by Players in 2024
Figure 15. Global Peptide CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Peptide CXO Revenue in 2024
Figure 17. North America Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Peptide CXO Market Share by Country (2020-2031)
Figure 19. United States Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peptide CXO Market Share by Country (2020-2031)
Figure 23. Germany Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peptide CXO Market Share by Region (2020-2031)
Figure 31. China Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peptide CXO Market Share by Country (2020-2031)
Figure 39. Mexico Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peptide CXO Market Share by Country (2020-2031)
Figure 43. Turkey Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Peptide CXO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Polypeptide Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 47. Bachem Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 48. LONZA Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 49. Bicycle Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 50. Pepscan Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 51. JPT Peptide Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 52. WuXi AppTec Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 53. Asymchem Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 54. Jiangsu Sinopep-Allsino Biopharmaceutical Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 55. Chinese Peptide Company Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 56. AmbioPharm Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 57. ReaLi Tide Biological Technology Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 58. GL Biochem Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 59. Shenzhen JYMed Technology Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 60. Chengdu Shengnuo Biotechnology Revenue Growth Rate in Peptide CXO Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
